Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
Great to see something in print from them, especially as it implies they're close to the endpoint in trials.
I'd assume that the glycation related product is totally different and nothing to do with WSTC though.
BB
Haha - I'm always grumpy, you should know that by now !
Plastic pots though ffs, why can't people just watch Gardeners World and admire the bloody plant pots !!
Gixer
"There's no point guessing". Probably not, but investing in something like Provexis involves guessing where the company will be in whatever timescale people think of, and how that might affect the sp, which both get discussed. If everything had to have a point then there's something to be said for closing this bulletin board down.
Nothing wrong with a bit of guesswork, so long as it's clear that's all it is, and it sure as hell beats talking about the merits of plastic pots over blister packs !
BB
If there's a sweepstake, I'll take .5p
Ah well, the line about “and expects to make a further loss during the year ending” was in the Annuals, so more cash is required, which all suggests we won’t be seeing any cash coming from By-Health this financial year from sales of FF, or at least, if we do, then not soon enough to have a meaningful effect.
Given they havn’t started all their trials yet, I think it's hard to see By-Health getting Blue Cap before Spring 2021 at the very earliest, so, tbh, us getting any cash from DSM for FF sales to By-Health before summer 2021 seems unlikely. That may have always been the case, but plainly COVID-19 hasn't helped.
On the bright side, our share of the profits from DSM is slowly ticking up, and FF+ is paying for itself. FF+ contributed about 40k to our cashflow, though I’d imagine about half of that got swallowed up by paying Ian a full time wage rather than a part time one, so it's still as next to meaningless as makes no difference.
Bag of a fag packet calculations suggest that at current growth rates for both DSM profit share and FF+ of roughly 20% per annum, then it’d take at least three years to get to break even, with, ever decreasing, annual fund raises needed to bridge the gap.
Bottom line, as an investment, this is a punt on By-Health coming good, financially, in the next year or so. With that in mind, it’s a stick it in the bottom drawer and check it occassionally now and then kind of punt.
Mind you, I wouldn’t be surprised to see an RNS in the next 3 or 4 weeks saying Lucas has gone ( up ) through another threshold so wtfdik !
BB
Re "If there was a cost saving then he should be mentioning it."
What a load of testicles. Any cost saving on packaging would be minor and make next to no difference to our cashflow, so I'd file that sort of info under "Excuse me if I don't give a damn" !
Admittedly, it's vaguely interesting to discuss the minor points of running a retail business, especially to those of us where it's not the day job, but FF+ is pretty much immaterial to Provexis as a whole, and packaging costs within FF+ are a small part of immaterial, so expecting Ford to discuss it, especially via a specific RNS or even a press release is nuts.
It might get a mention in a para in an Annual Report, but I sincerely hope it doesn't, because it'd just be filler.
BB
In theory, unless Lucas and family have added since his last holdings RNS, he'll have dropped under 9%.
Chances are, as he'd only need to have added roughly half a million since the 6th August to stay above 9%, then he has added, so he won't have had to inform the company of a movement across a threshold.
BB
Having full ownership of the BP IP is plainly good news. Depending on your point of view, viewing Oslo's share of that IP at 80k at yesterdays's share price could be good or bad. Good because it means next to no dilution to settle it, but bad because, well 80k isn't very much and doesn't exactly value that IP very much I'd caveat that by saying, firstly, I don't know what percentage split of the IP that 80k applies to, and also by saying that if Oslo hang onto those shares and the sp rises, then their return obviously rises too, but there's no way of knowing if they'll do that.
The COVID statement ( excluding the bit about supply issues ) is suitably vague and could mean anything between nothing and a massive opportunity.
With less than seven weeks to go to the publication of the Annual Report, mention of a further trading update is just weird. If there's price sensitive info to be released, then why not release it today ? If it's not price sensitive info then why not wait until you put the report out and include it in a post reporting period section ? Again, it could be anything ranging from positive news on the Bi-Health front to a fund raising, neither of which seem desperately likely in the next six or seven weeks, but wtfdIk.
Plainly we'll find out more by the end of September at the latest.
BB
I've been in here since it was something like £3.00 or £3.50 pre-consolidation, so the equivalent of 30 to 35p now, and have, while always keeping the majority of my holding, taken profits and added every so often, sometimes successfully, sometimes not.
fwiw - If the sp rises to something in the region of £5.25 to £5.50 ( so a fair amount above the warrants exercise price ) - I'll likely take some more profits, but as Davey found out when he sold up many years ago ( prior to him buying back quite a few years back ) it's nigh on impossible to know the right time to buy/sell.
BB
I think I've mentioned it before on here, but a lot of the RNS's Chimed issue are just RNS Reach's, and today's was another one.
For those that don't know ... an RNS Reach is basically information which should be viewed more as a Press Release than something which is deemed to be price sensitive. See https://www.lseg.com/areas-expertise/market-information/regulatory-news-service/rns-reach for more details.
If you just rely on this site ( lse ) to view RNS announcements, then there's nothing in the news section which makes it obvious if the news item is a regulatory requirement, or a Reach announcement. I've no idea why, it really wouldn't be that hard for them to do so.
If you want to know if it's a full RNS or just a Reach, then you need to go to a grown up site and look at something like https://www.londonstockexchange.com/stock/HCM/hutchison-china-meditech-limited/analysis where they make it obvious if it's a Reach.
Bottom line - if a Reach RNS is issued, then don't expect the sp to move because of it. Most of the grown ups will read it for what it is and pretty much ignore it. The sp might move up on a positive Reach RNS, so there could be a correlation there, but that doesn't necessarily link to cause
BB
there = their ffs !
Alf
What on earth is a "genuine holder", how do you measure it and why is it only there sells which count ? As far as i'm concerned the terms "genuine holder" and "long termers" are labels used by PIs to make themselves feel better about the fact that we're trying to get make money by doing nothing very much.
People buy and sell all the time, some buy for the long term, others are looking for a return in days rather than months. I don't doubt there'll be a lot of shares held by people who've had them for years, but equally there'll be others who've sold in the last few months who have turned a profit in the last few months and banked it.
If you think the MM's are making up 311 million shares bought or sold this year as part of some conspiracy by someone to get the company on the cheap, then, though that is a remote possibility, it's more likely that you're 'kin mad !!
Anyway, so basically the market is crooked and all the numbers are made up, and some people here think Stuart Lucas is manipulating the market to build up his holding. If true, it'll make a great TV programme, but I ain't holding my breath :)
BB
Alf
Re "who freed up all those shares for Mr L to buy? Or did MM's sell shares they didn't have, and then got active on the boards to try to drive down the sp ?"
Well, according to https://www.londonstockexchange.com/stock/PXS/provexis-plc/trade-recap just under 140 million shares were traded in June and July. On the assumption that pretty much half that volume were sales, that gives 70 million.
Lucas bought just over 20 million shares between the end of May and early August, which still leaves 50 million to spare, so, as conspiracy theories go, you're on a par with Wellsite !
Anyway, we'll see how the company was doing in the last FY sometime in the next 53 days ...
BB
Wellsite
Re a" seat on the board "- it's a possibility, he's a NED, or has been in the past at Daniel Stewart.
Re "he probably had a bit of help........" -Wow ! It almost sounds iike you're implying he's had people trying to drive the price down for him ? Nothing wrong with a bit of paranoia like, but that does sound a bit far fetched.
BB
No-one really knows when we'll be profitable. However, Edison in their research note are forecasting sustained profitability in 2024.
https://www.edisongroup.com/publication/eye-of-the-tiger/27214/
Don't mind me Alf !
Quite a few decent sized sells ( ? ), and at least, one big buy ( 5 million ).
By my reckoning, Lucas would have to buy ~20 million shares since his last declaration before he had to declare again ?
It's not beyond the realms of possibility that he's very far off that.
BB
Sock
I'd imagine it was as simple as SIS didn't sell enough of that particular product to turn a decent profit on it, so they dropped it and concentrated on products they thought were more likely to be big sellers and/or be high margin ?
BB
Jatw - it's not really the dilutive effect of the warrants which I was thinking of. It's more what they'll do with the exercised warrants. If General Atlantic exercise the warrants, but then hold the resulting shares, then that'll be great. But, if they exercise then sell into the market, that'll add to the number if shares being traded and might hold the sp back at something a bit north of 30 USD.
So we could see a situation where the ADR price rises to, say, 35USD, General Atlantic exercise, say, 10 million ADRs and sell at prices between 30 and 35 USD. They could rinse and repeat that a fair few times.
I guess a lot depends on the normal volume of trading of ADRs as to whether or not the drip feeding of exercised warrants would have much effect on the sp, and I'll happily admit that I don't know the normal sort of volume of ADRs which get traded is, so I could be typing rubbish here
BB
Nice to see money being raised without effective dilution.
There is one small downside though, in that I think the warrants are likely to effectively put a brake on any share price rises much above 30 USD for 18 months, or sooner if the market can easily handle another 100 million USD worth of ADRs ?
BB
On the A trades - I havn't a clue Alf.
On reducing, I had three profit points ( mentally ) set, it went through the first one, so I followed it. It's a mechanism which has served me well over many years. I tend to ignore stuff like what HNWI's are doing. For every successful Lucas there's likely a McKeeve as well.
Hammer, who posted here, on advfn and iii, used to ( don't think he still does ) work at Asset Match , and he knew far, far more about the markets than I ever will, but it didn't stop him being underwater here for a very long time. Hopefully he's fit, well and showing a profit now though.
Lucas's profile on asset match suggests he might have posted on iii at some time. Must admit, if he did post ( and it is if ) I kind of wonder who he posted as. I suspect he didn't post about Provexis though.
BB